Importantly, metformin fails to reduce cardiac injury in OVE26 type 1 diabetic mice overexpressing a dominant-negative AMPKα2 mutant, emphasizing the essential role of this isoform in protecting against diabetic cardiomyopathy (85). Here, PRKAA2 is linked to diabetic cardiomyopathy.